Milky Kao, MSc

My role as business development for TAHO Pharma began in 2015. I am currently responsible for all out-licensing commercial development activities for TAHO's proprietary transdermal and transmucosal drug delivery technology and assets. Prior to this position, I spent 3 years as formulation scientist at TAHO, developed several drug delivery technologies accredited with patents.

I earned my master of science degree at the National Taiwan University and over the years have continued my education by participating in various executive education programs in IP, executive management, regulatory, and data science.